| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Mitochondrial complex i assembly model oxphos system 0.7259109925846539 2.3801699225998103 0.0173046563665315 0.9999758393278996 0.9041570885449912 26 Q9NPL8,Q9Y6M9,O43674,O95139,O96000,O75380,P03886,O95182,O95168,O75306 10 |
| Glycerophospholipid biosynthetic pathway 0.7683427586025129 2.3289224530697252 0.0198631742174988 0.9999950613929536 0.9041570885449912 9 Q86UL3,O14735,Q9HCL2,Q32NB8 4 |
| Ketogenesis and ketolysis 0.924314986334421 2.3213460395000913 0.0202681753150684 0.9999961603270546 0.9041570885449912 5 P23786,P53985,O43772 3 |
| Cytosine methylation 0.8861995253228152 2.1713425240050257 0.0299052901100704 0.9999999906715604 0.9041570885449912 5 P48735 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.6575947519521083 2.13396607994671 0.0328455575462869 0.9999999985312054 0.9041570885449912 14 P23786,Q96CM8,O43772,Q16836,P11310 5 |
| Glycerolipids and glycerophospholipids 0.7256109658827011 1.933687929543158 0.053151508804631 0.9999999999999964 1.0 8 Q86UL3,Q9HCL2 2 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.8487047635116389 1.9278177372103784 0.0538778006971207 0.9999999999999978 1.0 4 Q07820,Q15554 2 |
| Tca cycle aka krebs or citric acid cycle 0.6007413392344669 1.9010195148913376 0.057299456554348 0.9999999999999998 1.0 15 O75390,P21912,P48735,O43837,P31040,Q02218 6 |
| Fatty acid betaoxidation 0.5848429844734956 1.766456733694452 0.0773192541710201 1.0 1.0 20 P23786,O43772,Q16836,P35610,P11310 5 |
| Photodynamic therapyinduced ap1 survival signaling 0.6893414897136336 1.765328278064072 0.077508609607789 1.0 1.0 8 Q07820,Q07812 2 |
| Tryptophan metabolism 0.5711231981531333 1.7333828442150518 0.0830276447942948 1.0 1.0 15 Q16836,P40939,Q15392,P35610,P51648 5 |
| Oxidative phosphorylation 0.6361257148853271 1.719786093546022 0.0854713313588566 1.0 1.0 32 O75964,Q9Y6M9,P24539,O95139,O96000,O75380,O00483,P03886,Q16795,O95182,O43674,O75306 12 |
| Fluoroacetic acid toxicity 0.7743960691181725 1.7177166249591458 0.0858483154585112 1.0 1.0 5 O75390,P51648 2 |
| Vitamin dsensitive calcium signaling in depression 0.7129628196409528 1.7047470320751092 0.0882416140677162 1.0 1.0 7 Q8NB78 1 |
| Dna mismatch repair 0.5731429496127478 1.6686784235836445 0.0951811274223288 1.0 1.0 21 Q9NR33,Q9UQ84,P41440 3 |
| Urea cycle and associated pathways 0.5931630515088745 1.645408518563919 0.0998855940202918 1.0 1.0 12 P00367,Q9Y619,P32322,O75746 4 |
| Estrogen receptor pathway 0.8868227289228305 1.6183357996906729 0.105590249521295 1.0 1.0 3 Q9HCL2 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5723887162347082 1.605194837802813 0.1084509331739531 1.0 1.0 23 P04035,O00767,Q03426,O75845,Q16850,Q15738,Q15392,P35610,Q14739,P48449,O95864 11 |
| Thiamine metabolic pathways 0.7413128713871716 1.5800539168177803 0.11409451953253 1.0 1.0 5 O14874,Q02218,Q9HC21 3 |
| Thyroid hormones production and peripheral downstream signaling effects 0.5333822622334279 1.559821592209213 0.1188020474208157 1.0 1.0 17 Q8N122,P62993,Q16539,Q9UNY4,P17612,P62753,P49815,O60343 8 |
| Tca cycle and deficiency of pyruvate dehydrogenase complex pdhc 0.5313724919591645 1.505679486482144 0.132149472460479 1.0 1.0 15 O75390,P31040,Q02218,P08559,O75874,P11498 6 |
| Adipogenesis 0.5233214897062503 1.500684279471436 0.1334372410242814 1.0 1.0 17 O00767,P43490,O75844 3 |
| Gastric cancer network 1 0.558336167783814 1.4586672532391551 0.1446567133081839 1.0 1.0 12 P25054,Q96Q89,P84243,P49454,P62805,O14965 6 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7121238570047618 1.4576139602879965 0.1449469794883193 1.0 1.0 5 Q07820,Q07812,Q9HB09 3 |
| Statin inhibition of cholesterol production 0.7069565685120027 1.4358619638121588 0.1510416236268503 1.0 1.0 5 P04035,Q8WTV0,P35610 3 |
| Copper homeostasis 0.6194784447528742 1.4345447495863413 0.1514168684733547 1.0 1.0 8 O75880 1 |
| Selenium micronutrient network 0.5425115346325025 1.4342343171716756 0.1515054070362835 1.0 1.0 13 Q13162,Q9NVS9,Q8NFF5,Q969G6,P30048,Q8WTV0,P00390 7 |
| Cholesterol biosynthesis pathway 0.5415626760046865 1.4290078970930074 0.1530019636689414 1.0 1.0 13 P04035,Q03426,O75845,Q16850,Q15738,P48449 6 |
| Follicle stimulating hormone fsh signaling pathway 0.58362938520122 1.4236012256424675 0.1545619408616998 1.0 1.0 9 P42345,Q16539,P62753,P17612,P49815 5 |
| Monoamine transport 0.8333823097266932 1.4163128232290394 0.1566839350373563 1.0 1.0 3 O15127,Q16539 2 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6786790881420925 1.4048115953139533 0.1600773101475217 1.0 1.0 6 Q07820,Q07812 2 |
| Phosphoinositides metabolism 0.6762365808295259 1.394313779976733 0.1632228714976338 1.0 1.0 6 Q8TBX8 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.6709476169189068 1.3715676394177323 0.1701980735857131 1.0 1.0 6 O95470,Q06136 2 |
| Omega9 fatty acid synthesis 0.6708734987181214 1.3712487487557306 0.170297426343347 1.0 1.0 6 O00767 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.4902607250529974 1.3368606215332317 0.1812681367458506 1.0 1.0 16 P25054,O60725,P42167,O75844 4 |
| Influence of laminopathies on wnt signaling 0.5338585708197167 1.3266045128644155 0.184639542239926 1.0 1.0 12 P25054,O60725,P50402,O75844 4 |
| Cholesterol biosynthesis with skeletal dysplasias 0.658090716896633 1.316204333201282 0.1881054697156985 1.0 1.0 6 O75845,Q16850,Q15392,Q15738 4 |
| Pilocytic astrocytoma 0.8013517484572235 1.294838423285382 0.1953759740972702 1.0 1.0 3 P21359,Q06124 2 |
| Triacylglyceride synthesis 0.6720674624214862 1.2885931704169098 0.1975395589888493 1.0 1.0 5 Q9NUQ2,Q9HCL2 2 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.5466767671354016 1.2852165397103812 0.1987166254414691 1.0 1.0 10 Q8NHM5,Q9P0M6,P84243 3 |
| Photodynamic therapyinduced hif1 survival signaling 0.5291247818196247 1.2456558683461472 0.2128907620514373 1.0 1.0 11 Q07820,P53985 2 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.7859634943062828 1.2365153708658667 0.2162670557990929 1.0 1.0 3 P32121 1 |
| Imatinib and chronic myeloid leukemia 0.7858243325492764 1.235988278213488 0.2164629208116832 1.0 1.0 3 P08183 1 |
| Valproic acid pathway 0.6320588235294176 1.2039304787200198 0.2286164502910637 1.0 1.0 6 P26440,P40939,Q13547,P55084,P45954 5 |
| Wnt signaling pathway 0.4703013380961726 1.1536861719394818 0.2486288551382147 1.0 1.0 15 P25054,P42345,P32121,P49840,P49815,P17252,Q00534,P63000 8 |
| Type ii interferon signaling ifng 0.6365950906666954 1.1386577013389338 0.2548459515780257 1.0 1.0 5 Q06124 1 |
| Kallmann syndrome 0.6363997899090624 1.137833225890574 0.255190128093433 1.0 1.0 5 Q06124,Q9P2D1,P62993 3 |
| Cannabinoid receptor signaling 0.61569926789214 1.1333767200552065 0.2570560860552611 1.0 1.0 6 Q16539 1 |
| Mitochondrial complex iv assembly 0.4855809015023887 1.1204876601833709 0.2625060081559458 1.0 1.0 13 Q9BSH4,O43819,O00483,P10606,Q7KZN9,P14406 6 |
| Insulin signaling in adipocytes diabetic condition 0.6509962257211295 1.116816775916117 0.2640726744368649 1.0 1.0 4 P62753,O60343 2 |
| Insulin signaling in adipocytes normal condition 0.6509962257211295 1.116816775916117 0.2640726744368649 1.0 1.0 4 P62753,O60343 2 |
| Oxidation by cytochrome p450 0.6049008986347307 1.0868682996925665 0.2770950178026836 1.0 1.0 6 Q9UHQ9,Q16850 2 |
| Amyotrophic lateral sclerosis als 0.4791834141361702 1.085404002952388 0.277742760249783 1.0 1.0 13 Q9BUN8,Q07812 2 |
| Folate metabolism 0.4465148603905329 1.079419207612781 0.2804008922079464 1.0 1.0 16 Q8WTV0,P41440 2 |
| Apoptosis modulation and signaling 0.4355540314676447 1.0156795808016588 0.3097819947017641 1.0 1.0 16 Q07820,Q9Y3E5,O95831,P55212,Q07812 5 |
| Nanomaterial induced apoptosis 0.5252226775359692 0.9824224603425996 0.3258917656826352 1.0 1.0 8 P55212,Q07812 2 |
| Apoptosis modulation by hsp70 0.5746311129492991 0.9570923752504228 0.3385206317708196 1.0 1.0 6 P55212,O95831 2 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.4523754505342521 0.9395703504862069 0.3474379907139748 1.0 1.0 13 P62753,Q06124 2 |
| Pregnane x receptor pathway 0.5874624840941545 0.9324661908215762 0.3510956513264105 1.0 1.0 5 P08183 1 |
| Vitamin b12 disorders 0.7046387108084821 0.9314441809319814 0.3516238459678242 1.0 1.0 3 Q96EY8 1 |
| Parkinsons disease pathway 0.5082208421009395 0.9017179758483734 0.367206701514146 1.0 1.0 8 P55212 1 |
| Cytoplasmic ribosomal proteins 0.636349741031628 0.8939210859489486 0.3713641150073625 1.0 1.0 75 P46777,Q07020,P61353,P36578,P49406,P84098,P39023,P62910,P62081,P47914,P61927,P62829,P62857,P83881,P15880,P62851,Q02543,P62750,P61254,P62854,P18621,P08708,P49207,P50914,P61313,P27635,P32969,P62263,P26373,P30050,P46779,P18124,P62753,P62266,P83731,P60866,P62906,P61247,Q02878,P46781,P46782,P42766,P62701,P40429,P62277,P62424,P62269,P62241,P62847,P62917,P62913,P46776 52 |
| Ppar signaling pathway 0.416611101450789 0.8515364864956465 0.3944714041158641 1.0 1.0 18 P23786,O00767,Q15067,O95864 4 |
| Acute viral myocarditis 0.4072239854423787 0.8263714001551996 0.4085934419511168 1.0 1.0 17 P55212,Q14118 2 |
| Estrogen signaling pathway 0.5420270815515281 0.8191599688810921 0.4126951509074312 1.0 1.0 6 Q16539 1 |
| 1q211 copy number variation syndrome 0.455841762048259 0.8175790445624868 0.413597597268696 1.0 1.0 10 Q07157,Q9Y624,P54646 3 |
| Electron transport chain oxphos system in mitochondria 0.5459081414502502 0.8068661670375855 0.4197435929697777 1.0 1.0 51 P31930,P12235,O75880,Q9Y6M9,O95182,O95168,O43674,P14406,P24539,O75306,O95139,P05141,O96000,O75380,O00483,P03886,P12236,O75964,Q16795 19 |
| Ketone bodies synthesis and degradation 0.6664690247060017 0.7923898122003925 0.4281334179126168 1.0 1.0 3 P35610 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4487864174751542 0.7822531718044762 0.4340658014354641 1.0 1.0 10 P04035,Q03426,P35914,P37268,P35610,Q13907,P14324 7 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.5317916166750478 0.7764753717906446 0.4374683569015727 1.0 1.0 6 P04035,O00767 2 |
| Vitamin b12 metabolism 0.5038397164473347 0.7634488405808094 0.4451957617849882 1.0 1.0 7 Q8WTV0 1 |
| Omega3 omega6 fatty acid synthesis 0.5283541525041362 0.7622238324335996 0.4459264243580381 1.0 1.0 6 Q15067 1 |
| Il2 signaling pathway 0.4418566207414831 0.7478213534296766 0.4545679203779058 1.0 1.0 10 P62753 1 |
| Biotin metabolism including iems 0.4983888575083583 0.7397225276627285 0.4594683758810154 1.0 1.0 7 Q96RQ3,P05166,P11498 3 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4587939854843242 0.7382242618522767 0.4603781818516688 1.0 1.0 32 P04035,O00767,P54646,Q16850,Q9HCL2,P17612,P48449,Q8WTV0,O95486,O95487 10 |
| Dna damage response 0.4200067964693653 0.7184535463986829 0.4724776808433948 1.0 1.0 24 P14635,O60934,O95067,Q07812,Q00534,P41440 6 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.5346476038508344 0.7167371867330836 0.4735362758963122 1.0 1.0 5 O60934 1 |
| Common pathways underlying drug addiction 0.4413637768930871 0.7064759452233647 0.4798922067305557 1.0 1.0 9 P63096,P17252,P17612 3 |
| Base excision repair 0.3875358655027121 0.6935431003721545 0.4879687875350478 1.0 1.0 18 P13051 1 |
| Drug induction of bile acid pathway 0.8733842538190323 0.6929668474205496 0.488330356980641 1.0 1.0 2 P08183 1 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.485977043192967 0.6862246990578329 0.492571424924572 1.0 1.0 7 Q16539 1 |
| Pi3kaktmtor vitd3 signaling 0.5076928854463834 0.6776048953208079 0.498022241413099 1.0 1.0 6 P49815,P54646,P08559 3 |
| Nicotine effect on dopaminergic neurons 0.5239617716444573 0.6743893854811903 0.5000637892692081 1.0 1.0 5 P63096,P17612 2 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.4264801167702391 0.6725228558800435 0.5012508946291323 1.0 1.0 10 P25054,P19784,Q86UE4,P68400,P67870 5 |
| Proteoglycan biosynthesis 0.5230052834004436 0.6706265403969793 0.5024584706496587 1.0 1.0 5 Q96L58,Q9NX62,Q8WVQ1 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3996299181854433 0.6212979978139334 0.5344035708199577 1.0 1.0 12 Q9UI14 1 |
| Nanoparticlemediated activation of receptor signaling 0.4469852398849953 0.6200995622662838 0.5351922403588274 1.0 1.0 8 Q9Y490,P62993,Q16539 3 |
| Progeriaassociated lipodystrophy 0.4229772840580951 0.618852919575051 0.5360132563367834 1.0 1.0 9 O60725 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.377307254993061 0.5935877236096013 0.5527878939660553 1.0 1.0 20 P25054,Q07812,P11234,P11233 4 |
| Mirna regulation of dna damage response 0.3991811881354895 0.5913258923295899 0.5543020841445776 1.0 1.0 25 P14635,O60934,O95067,Q07812,Q00534,P41440 6 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4400011859721859 0.5893801098814859 0.5556063161875551 1.0 1.0 8 Q15118,P17252,P32121 3 |
| Familial partial lipodystrophy fpld 0.4629005183770029 0.5891077499245135 0.5557889949115746 1.0 1.0 7 O60725 1 |
| Autosomal recessive osteopetrosis pathways 0.8254994124559284 0.5529282730091414 0.5803125264750331 1.0 1.0 2 P51798 1 |
| Thermogenesis 0.4121922111253355 0.5328911327340989 0.5941089437679454 1.0 1.0 31 Q8N122,P23786,O43772,Q16539,P62753,Q96GM5 6 |
| Hypertrophy model 0.5888921539817722 0.5273336501422945 0.5979619103130656 1.0 1.0 3 P06730,P20248 2 |
| Aspirin and mirnas 0.8160987074030515 0.5267396812398014 0.5983743754882989 1.0 1.0 2 O15439 1 |
| Rala downstream regulated genes 0.4631512900433955 0.5033443508652488 0.6147221896483286 1.0 1.0 6 P63000,P11233 2 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3478152913573218 0.496376066395128 0.619629107812071 1.0 1.0 15 P25054,P19784,Q9P0M6,P68400,P67870,Q00534 6 |
| Urea cycle and related diseases 0.8043478260869468 0.4946909766174711 0.6208182719622479 1.0 1.0 2 Q9Y619 1 |
| Mirna regulation of prostate cancer signaling pathways 0.4153428900556917 0.4843067019182026 0.6281682203253043 1.0 1.0 8 P62993,Q8NCF5,P42345 3 |
| Arrhythmogenic right ventricular cardiomyopathy 0.3613186176158625 0.4799913520398909 0.631233542307456 1.0 1.0 13 Q14118 1 |
| Interferon type i signaling pathways 0.3388056383892617 0.4747272056332501 0.6349814240874891 1.0 1.0 17 Q8N122,P62753,Q06124 3 |
| Exrna mechanism of action and biogenesis 0.4847783921574782 0.4688408521666427 0.6391833969329797 1.0 1.0 4 Q8WYQ5,Q8IV48 2 |
| Mitochondrial complex ii assembly 0.7923031727379533 0.4626817996460545 0.6435924659389904 1.0 1.0 2 P21912 1 |
| Hair follicle development organogenesis part 2 of 3 0.5678034933946046 0.4613693548706277 0.6445336339714367 1.0 1.0 3 Q9BZE4 1 |
| Histone modifications 0.4095072440939084 0.4603292397188621 0.6452799165225227 1.0 1.0 8 P84243 1 |
| Riboflavin and coq disorders 0.4220181097004895 0.427260944845543 0.6691892757371571 1.0 1.0 7 Q969G6 1 |
| Tcell activation sarscov2 0.3396637344235382 0.4212448730019214 0.6735762803516767 1.0 1.0 14 Q8N122,Q07812,P62993,P49815 4 |
| Nonalcoholic fatty liver disease 0.4569570566845044 0.4100390398858909 0.6817773095453512 1.0 1.0 51 P31930,P60953,Q9Y6M9,O95182,O95168,O43674,P14406,P21912,Q07812,P08574,O75306,P31040,O95139,O96000,O75380,O00483,P10606,P15954,P54646,Q16795,P63000 21 |
| Apoptosis 0.3277737787597202 0.4069322211112925 0.6840577699574988 1.0 1.0 15 Q07820,P55212 2 |
| Pparalpha pathway 0.3943260990796999 0.3998183035005146 0.6892903484326212 1.0 1.0 8 P23786 1 |
| Oncostatin m signaling pathway 0.3253410442750919 0.3962468579049948 0.6919229266452493 1.0 1.0 18 P42345,P62993,P36507,Q16539,P62753,P20248,P17252,Q06124 8 |
| Neuroinflammation 0.4327071402493643 0.3932887567982868 0.6941062213605784 1.0 1.0 6 Q16539 1 |
| Pyrimidine metabolism 0.4247305380249781 0.380261599559253 0.7037512374229318 1.0 1.0 44 Q9H773,Q9NR33 2 |
| Netrinunc5b signaling pathway 0.3199311051669605 0.3742655573416005 0.7082067543175337 1.0 1.0 15 Q06124 1 |
| Interactions between loxl4 and oxidative stress pathway 0.5360742056366989 0.3688159193736666 0.7122649379777148 1.0 1.0 3 Q8TAG9 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3181986961377006 0.3671601386284773 0.7134995707812481 1.0 1.0 18 P50402,P42167,Q14739,Q9BTV4 4 |
| Prostaglandin and leukotriene metabolism in senescence 0.7532314923619153 0.365343416283739 0.7148550733893655 1.0 1.0 2 P09960 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.5330590655304149 0.3604894251580834 0.7184811633059971 1.0 1.0 3 P08195,Q14145 2 |
| Pdgf pathway 0.3158375996901383 0.357785201646825 0.7205040658666719 1.0 1.0 15 P63000,Q06124,P53365,P62993 4 |
| Metabolic reprogramming in colon cancer 0.3899256852578628 0.3472222221857703 0.728424377296331 1.0 1.0 37 P21912,P48735,P32322,Q96C36,P00367 5 |
| Hereditary leiomyomatosis and renal cell carcinoma pathway 0.3363796535124058 0.3408829710066728 0.7331916850219575 1.0 1.0 12 Q15118,P62753,Q13618 3 |
| P38 mapk signaling pathway 0.377227658297427 0.3353009576979618 0.7373980713664434 1.0 1.0 8 P63000,P62993,Q16539 3 |
| Metastatic brain tumor 0.5210559765484232 0.328219254934384 0.7427458902143123 1.0 1.0 3 Q00534 1 |
| Proximal tubule transport 0.3400657432086485 0.32504805605733 0.745144701247191 1.0 1.0 11 O15439,Q9UI12,Q9Y5K8,P08183 4 |
| Gaba metabolism aka ghb 0.7353113983548734 0.3243679133656958 0.7456595090379852 1.0 1.0 2 P51649 1 |
| Target of rapamycin tor signaling 0.3121084856164161 0.310785894978474 0.7559633932460543 1.0 1.0 14 Q8N122,P04035,P54646,P60953,Q6PHR2,P63000,P49815 7 |
| Lipid metabolism pathway 0.3253938884132527 0.299366154093627 0.7646606837717533 1.0 1.0 12 P54646,P17612,P08559,Q13085,P17252 5 |
| Dna irdouble strand breaks and cellular response via atm 0.3362067607285464 0.2960698333575859 0.7671767512316956 1.0 1.0 27 Q9UQ84,P54132,Q07812,Q15554 4 |
| Physicochemical features and toxicityassociated pathways 0.2835441181020888 0.2582155286142588 0.7962405741056691 1.0 1.0 17 P07737 1 |
| Embryonic stem cell pluripotency pathways 0.3127978358902323 0.2550489232771111 0.7986853130595593 1.0 1.0 12 P25054 1 |
| Urea cycle and metabolism of amino groups 0.3530425332598506 0.2517244514212141 0.8012540559483741 1.0 1.0 8 P32322 1 |
| Endometrial cancer 0.2903693244973896 0.2366267241762136 0.8129463860055615 1.0 1.0 14 P25054 1 |
| Transcription cofactors ski and skil protein partners 0.3828165954603648 0.2356967841387959 0.813667965487658 1.0 1.0 6 P21359 1 |
| Integrated cancer pathway 0.2710480411846552 0.2328308083831622 0.8158927886410583 1.0 1.0 16 Q07812,P53350 2 |
| Gastric cancer network 2 0.2779016517505088 0.2258170432382788 0.8213437208489334 1.0 1.0 15 Q86UE4,Q8TDN6,Q8WYP5 3 |
| Tumor suppressor activity of smarcb1 0.2771362738547229 0.2235684243826118 0.8230931354543998 1.0 1.0 15 Q96GM5 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.3024902211952778 0.2215726900339214 0.8246465442518598 1.0 1.0 12 Q7Z434,Q6PKG0,Q53FA7,Q13158,P78406 5 |
| Wnt signaling 0.2641706263695854 0.2133653546511124 0.8310420012792701 1.0 1.0 16 P25054,P48729,P19784,P68400,P67870,P17252,P63000,O75116 8 |
| Cohesin complex cornelia de lange syndrome 0.2716413562341579 0.2114871499051693 0.8325071583451344 1.0 1.0 18 P25054,Q7Z5K2,Q96GD4,Q9Y6X3,P53350,Q16537 6 |
| Rac1pak1p38mmp2 pathway 0.2731553853444114 0.2048896441018453 0.8376583463932796 1.0 1.0 19 Q07812,Q06124 2 |
| Dna damage response only atm dependent 0.2811231018769904 0.2048535573212524 0.8376865415177148 1.0 1.0 21 P25054,P62993,O00443,Q15118,Q07812,P63000,Q16537 7 |
| Angiopoietinlike protein 8 regulatory pathway 0.3164351528948128 0.197614833124319 0.8433464285145154 1.0 1.0 31 Q8N122,P41440,O00767,Q16539 4 |
| Nucleotide excision repair 0.2852648091619203 0.1782750362475035 0.8585069829443563 1.0 1.0 25 P41440,Q9NR33 2 |
| Regulatory circuits of the stat3 signaling pathway 0.3115426555780004 0.1769106808657012 0.8595785488371313 1.0 1.0 9 Q8N122 1 |
| Proteasome degradation 0.3442521934798647 0.1747020524713936 0.8613137549404826 1.0 1.0 42 O00233,P49721,O43242,P28074,P20618,P60900 6 |
| Mitochondrial fatty acid synthesis pathway 0.6474735605170403 0.1622151582876367 0.8711364233058374 1.0 1.0 2 Q53GQ0 1 |
| Hedgehog signaling pathway wp4249 0.3369263000946686 0.1572989313133973 0.8750092624632568 1.0 1.0 7 P32121 1 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.2787484882261039 0.154668405578199 0.877082738905244 1.0 1.0 12 Q8N122,Q13057 2 |
| Dna replication 0.2931985725891322 0.1512259354267487 0.8797974920530374 1.0 1.0 31 P41440,Q9Y619 2 |
| Robo4 and vegf signaling pathways crosstalk 0.6377790834312529 0.148514028146155 0.8819371158612048 1.0 1.0 2 P63000 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.3686067019400467 0.1470842025247417 0.8830655588184146 1.0 1.0 4 P19525,Q7Z434,Q9UHD2 3 |
| Ampactivated protein kinase ampk signaling 0.2494299438997192 0.1454530801629195 0.8843531583086652 1.0 1.0 20 P14635,Q8N122,P04035,P54646,P20248,P49815 6 |
| Leptin and adiponectin 0.3668430335097101 0.1436469415472273 0.8857792710304149 1.0 1.0 4 Q13085,P50416,P54619 3 |
| Atm signaling in development and disease 0.2628970076308579 0.1429570569037114 0.8863240963870374 1.0 1.0 24 P06493,O60934,Q96GD4,O43683,Q14739,P49815 6 |
| G13 signaling pathway 0.2353953562789098 0.1409114666315378 0.8879398834746111 1.0 1.0 17 P46940,P07737,P63000,O75116,Q14344 5 |
| Aflatoxin b1 metabolism 0.624853113983546 0.1315596074588735 0.8953326363242458 1.0 1.0 2 O43488 1 |
| Regulation of actin cytoskeleton 0.3197190473503745 0.1306784190063231 0.8960297050640964 1.0 1.0 43 P25054,P46940,Q8TBX8,P62070,O00443,P07737,Q96F07,P63000,Q9UQB8,O75116,Q14344,Q14155 12 |
| Cytosolic dnasensing pathway 0.2344311121768082 0.125470505928512 0.9001510733500422 1.0 1.0 15 P52434,Q9H1D9 2 |
| Rett syndrome causing genes 0.2200589970501567 0.1228727475230128 0.902207866395042 1.0 1.0 16 P51608,Q14839,P12268,P42858,Q14683,Q9HCS7,Q8WXH0,P46108,Q9BZK7,Q13547,O75376,P27695,P51532,P49770,P28370 15 |
| Complement system 0.2532331575821097 0.1191520449836833 0.9051548984595144 1.0 1.0 13 P07942,P32121,P17612,P17252,P08754 5 |
| Hepatitis c and hepatocellular carcinoma 0.2505857716791468 0.1140883903034154 0.909167725326688 1.0 1.0 13 Q06124 1 |
| Glycosylation and related congenital defects 0.2695656003185401 0.1119841628342461 0.9108359638062352 1.0 1.0 11 Q10469,Q9H0U3 2 |
| Complement and coagulation cascades 0.4072876873347053 0.1035831700831933 0.9175001441371792 1.0 1.0 3 P49257,Q00610 2 |
| Endoplasmic reticulum stress response in coronavirus infection 0.2982107675056887 0.1027078814566879 0.9181948182317156 1.0 1.0 8 Q15435 1 |
| Alpha 6 beta 4 signaling pathway 0.2438879555319183 0.1021078576927963 0.9186710640793638 1.0 1.0 13 P62993,Q16539,P07942,P63000,Q06124 5 |
| Dna repair pathways full network 0.3097400440195144 0.1009243262092599 0.919610532177243 1.0 1.0 50 Q9NR33,P13051,Q9UQ84,P41440 4 |
| Energy metabolism 0.253146099952066 0.0990859878732609 0.9210699973923152 1.0 1.0 12 Q13547,P54646,Q16539 3 |
| Fragile x syndrome 0.3041338572190632 0.0990587382875624 0.9210916329748312 1.0 1.0 49 Q8N122,Q9Y4R8,P51649,Q14118,P17612,P51452,Q15118,Q96F07,P21359,P49815,P53985,P51648,Q06124 13 |
| Mevalonate pathway 0.3328518594922278 0.0982529085914539 0.9217314706808452 1.0 1.0 5 Q03426 1 |
| Vegfavegfr2 signaling pathway 0.1834459823452346 0.0946705927824126 0.924576476600402 1.0 1.0 189 P48735,P60953,P32121,P61353,O43852,P20248,Q9NZB2,Q02978,Q9UG63,Q9UM54,P62993,Q02543,Q16658,P61254,Q15293,P00367,Q9H2U1,P18124,P62753,P62906,Q13547,Q14241,Q96AG4,Q8N3C0,Q06124,Q7Z478,Q9NQ29,P46940,P54646,Q16539,Q15075,P40429,P07737,Q6KCM7,Q9UNN5,P09543,Q13158,P63000,O75116,Q12965,P04083 41 |
| G protein signaling pathways 0.19751844794037 0.0946515930341785 0.9245915684375936 1.0 1.0 17 Q92667,P63096,P17612,O43823,P08754,Q14344 6 |
| Amino acid metabolism 0.306239975018891 0.0939623073958822 0.925139098561921 1.0 1.0 53 Q16836,Q96RQ3,P08243,P32322,P11498,O75874,P40939,P11310,P00390,P00367 10 |
| Nucleotide excision repair in xeroderma pigmentosum 0.2533774994917309 0.0930019290749473 0.9259020286864524 1.0 1.0 35 P35244,P41440,Q9NR33 3 |
| Gastrin signaling pathway 0.2381466143696764 0.0912606856213029 0.9272854559155576 1.0 1.0 31 P62753,P32121,Q06124,Q16539 4 |
| Serotonin htr1 group and fos pathway 0.2777205784858723 0.0900449586415239 0.9282514880830186 1.0 1.0 9 P63096,P08754,Q16539 3 |
| Sarscov2 b117 variant antagonises innate immune activation 0.3952394945636213 0.0890137750185094 0.9290709626965096 1.0 1.0 3 Q7Z434,Q9UHD2 2 |
| G1 to s cell cycle control 0.2213978268981145 0.0872233055771319 0.9304940147797756 1.0 1.0 28 P06493,P14635,P49642,P15927,Q9Y619,P35244,Q07864,Q00534 8 |
| T cell receptor and costimulatory signaling 0.3178825437697672 0.0866100136509467 0.9309815060714 1.0 1.0 6 Q15118,P17252,P49840 3 |
| Exerciseinduced circadian regulation 0.2008257151282861 0.0835297700232943 0.933430307042922 1.0 1.0 15 P11142,P25789,P21266,Q96KR1,P31689,Q9Y2A7,Q12874,Q13185,Q96PU8,Q16851,Q9P0L0,Q00577,Q13907,P78344 14 |
| Corticotropinreleasing hormone signaling pathway 0.1938765884579123 0.0830076219704161 0.9338454790760864 1.0 1.0 22 P32121 1 |
| Dual hijack model of vif in hiv infection 0.3890684689979437 0.0822120293066968 0.9344781078249396 1.0 1.0 3 Q15369,Q93034 2 |
| Alzheimers disease and mirna effects 0.239640922664661 0.0818010779090028 0.9348048989013562 1.0 1.0 93 P25054,P49721,O00233,P12236,O43242,P28074,P20618,P12235,P30405,Q9Y277,Q9NQC3,O95197,P05141,Q96IX5,P60900 15 |
| Alzheimers disease 0.2250852300093035 0.0815260862062368 0.9350235801315074 1.0 1.0 91 P25054,P49721,O00233,P12236,O43242,P28074,P20618,P12235,P30405,Q9Y277,Q9NQC3,O95197,P05141,P60900 14 |
| Malignant pleural mesothelioma 0.1908584976924095 0.0792451144265587 0.9368376612721404 1.0 1.0 74 P25054,Q8N122,Q07820,P62753,Q08722,Q07812 6 |
| Retinoblastoma gene in cancer 0.245563372903437 0.0790134097349558 0.9370219569854166 1.0 1.0 49 P04818,P20248,P14635,P35244,P26358,Q14527,Q07864,Q00534,P06493,P09884,Q9Y619,P33981,O95067,Q13547,O95239,P49642,P15927,Q13309,Q9UNN5 19 |
| 22q112 copy number variation syndrome 0.2096460531695292 0.0777820481106654 0.9380014267124102 1.0 1.0 35 Q13618,P53007,Q9NQC3,Q8WYQ5,P62805,Q92890,O75376,P53350,P00367 9 |
| Leptin signaling pathway 0.1928166192266224 0.0760380368722802 0.939388836731666 1.0 1.0 33 P54646,P42345,P62993,P60953,Q16539,P62753,Q07812,P63000,O75116,Q06124 10 |
| Translation factors 0.1537240828746894 0.0742926655516831 0.9407775129470471 1.0 1.0 36 O75153,P26641 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.2242852932508142 0.0735933623691425 0.9413339528802632 1.0 1.0 13 O00303,P55010,P20042,P05198,O15371,O75821,P55884,Q13347,O15372,O75822,P60228,Q14152 12 |
| Neuroinflammation and glutamatergic signaling 0.137034849379807 0.072866938013426 0.941912003622472 1.0 1.0 20 Q13555,P34896,P08559,P09622,P62136,Q8TDW0,P34897,P17612,Q9Y617,P23528,P40763,P28482,P17174,P27361,P10515,P62140,P17252,O94925,P42224 19 |
| Ethanol metabolism production of ros by cyp2e1 0.561692126909512 0.0693092421521471 0.9447434692571388 1.0 1.0 2 P36507 1 |
| Sars coronavirus and innate immunity 0.3684983837790194 0.0626243133332993 0.950065668173883 1.0 1.0 3 Q7Z434,Q9UHD2 2 |
| Purinergic signaling 0.3525400622829623 0.0504824908860069 0.9597379018617008 1.0 1.0 3 P63096 1 |
| Hepatocyte growth factor receptor signaling 0.1959917477158902 0.0475392146561454 0.9620834768753788 1.0 1.0 13 P62993,P36507,Q16512,Q05397,P05556,P46108,P40763,P28482,Q02750,Q06124,P46109,P27361 12 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.267804590935852 0.0470733928908671 0.9624547332193708 1.0 1.0 8 Q96KB5,P36507,P42345,Q13131,P28482,Q02750,P06730 7 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.2657423036492379 0.0439973312929647 0.9649065311289816 1.0 1.0 8 Q15648,Q16539 2 |
| 15q133 copy number variation syndrome 0.3400425147741446 0.042661091953876 0.9659716954378637 1.0 1.0 3 Q16658 1 |
| Mitochondrial complex iii assembly 0.2745970415429831 0.0395936663386623 0.9684170770108091 1.0 1.0 7 P31930,P08574,P22695 3 |
| Krebs cycle disorders 0.2772713907674218 0.0283308216066605 0.9773982983734596 1.0 1.0 5 P07954,P36957,Q9P2R7,Q96I99 4 |
| Neural crest differentiation 0.2553692262430191 0.0176327727525574 0.98593181186139 1.0 1.0 7 P35222,P05556,Q13547,Q06330,P19022,Q92769 6 |
| Overview of interferonsmediated signaling pathway 0.3683901292596944 0.0174352090947073 0.9860894206239608 1.0 1.0 2 P17252 1 |
| Epo receptor signaling 0.2339611536197827 0.0069027004242328 0.994492485640032 1.0 1.0 8 P62993,P36507,P42224,P28482,Q15118,Q02750,P27361 7 |
| Pdgfrbeta pathway 0.2339611536197779 0.0069027004242286 0.9944924856400356 1.0 1.0 8 P62993,P42224,P19174,P19525,P17252,Q02750,P27361 7 |
|
|
